Connect
MJA
MJA

Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders

David van der Poorten, Dianna T Kenny and Jacob George
Med J Aust 2008; 188 (10): 610-614.

Summary

Objectives: To define and compare the prevalence, risk factors and understanding of hepatitis C transmission among Aboriginal and non-Aboriginal young offenders.

Design, participants and setting: Cross-sectional study of young offenders (aged 12–19 years; median age, 16.6 years) in custody or serving community orders with the New South Wales Department of Juvenile Justice who participated in a physical and mental health survey between March 2002 and December 2005, and who provided blood samples for analysis of biochemistry, bloodborne viruses and sexually transmitted infections.

Main outcome measures: Risk factors and prevalence of hepatitis C antibody positivity.

Results: Of the 1042 young offenders studied, 709 provided blood samples, 179 (25%) of whom identified as Aboriginal. Aboriginal adolescents had more markers of social disadvantage and higher rates of hepatitis B (9.6% v 5.2%; P = 0.04) than non-Aboriginal young offenders. Hepatitis C rates were high in both groups (7.3% v 5.3%; P = 0.33). Risk factors for hepatitis C were the same in both groups, the most important being injecting drug use (OR, 19; P < 0.001) and prior use of heroin (OR, 15; P < 0.001). Current custodial sentence doubled the risk of hepatitis C. Knowledge of hepatitis C transmission was very poor in both groups, with over 50% not knowing how it is transmitted and fewer than 10% able to identify sharing needles as a risk.

Conclusions: Hepatitis C rates are extremely high in all young offenders, and interventions to halt its spread are urgently needed. Aboriginal adolescents, who are over-represented in this population, are particularly at risk.

  • David van der Poorten1
  • Dianna T Kenny2
  • Jacob George1

  • 1 Storr Liver Unit, Westmead Millennium Institute, University of Sydney, Westmead Hospital, Sydney, NSW.
  • 2 Faculty of Health Sciences, University of Sydney, Sydney, NSW.

Correspondence: davidvdp1@gmail.com

Acknowledgements: 

This study was funded by an Australian Research Council Linkage Grant, LP0347017, to Dianna Kenny and Christopher Lennings; the University of Sydney, Australia; and industry partners NSW Department of Juvenile Justice (Mark Allerton) and Justice Health. The views expressed in this article do not necessarily reflect those of the industry partners. We thank Paul Nelson for project and data management, Keith Westbury for assistance with the pathological tests and Karen Byth for advice on statistical analysis.

Competing interests:

None identified.

  • 1. National hepatitis C strategy 2005–2008. Canberra: Australian Government Department of Health and Ageing, 2005: 5-7. http://www.health.gov.au/internet/wcms/publishing.nsf/content/842512152658C98ECA257030001CE904/$File/strategy-0508.pdf (accessed Apr 2008).
  • 2. Hepatitis C Estimates and Projections Working Group. Estimates and projections of the hepatitis C virus epidemic in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, 2006.
  • 3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832.
  • 4. Davis TM, McAullay D, Davis WA, Bruce DG. Characteristics and outcome of type 2 diabetes in urban Aboriginal people: the Fremantle Diabetes Study. Intern Med J 2007; 37: 59-63.
  • 5. Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Social Survey, 2002. Canberra: ABS, 2004. (Cat. No. 4714.0)
  • 6. Kenny DT, Nelson PK. Young offenders on community orders: health, welfare and criminogenic needs. Sydney: Sydney University Press, 2008.
  • 7. Murray KF, Richardson LP, Morishima C, et al. Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics 2003; 111: 153-157.
  • 8. Ogilvie EL, Veit F, Crofts N, Thompson SC. Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre: risk factors and challenges. J Adolesc Health 1999; 25: 46-51.
  • 9. van der Poorten D, Kenny DT, Butler T, George J. Liver disease in adolescents: a cohort study of high-risk individuals. Hepatology 2007; 46: 1750-1758.
  • 10. Butler TG, Dolan KA, Ferson MJ, et al. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 1997; 166: 127-130. <MJA full text>
  • 11. Hepatitis Australia workshop report. Hepatitis C and Aboriginal and Torres Strait Islander Communities: engaging communities workshop. Canberra: Hepatitis Australia, 2007.
  • 12. Australian National Council on AIDS and Related Diseases Working Party on Indigenous Australians' Sexual Health. The National Indigenous Australians' Sexual Health Strategy 1996–97 to 1998–99. Canberra: Looking Glass Press, 1997.
  • 13. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003; 26: 171-184.
  • 14. Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005; 41: 177-186.
  • 15. Champion JK, Taylor A, Hutchinson S, et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol 2004; 159: 514-519.
  • 16. Crofts N. A cruel and unusual punishment. Med J Aust 1997; 166: 116. <MJA full text>

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.